Search results for "Vascular endothelial growth factor"

showing 10 items of 320 documents

Let it flow: Morpholino knockdown in zebrafish embryos reveals a pro-angiogenic effect of the metalloprotease meprin alpha2.

2010

BACKGROUND: Meprin metalloproteases are thought to be involved in basic physiological functions such as cell proliferation and tissue differentiation. However, the specific functions of these enzymes are still ambiguous, although a variety of growth factors and structural proteins have been identified as meprin substrates. The discovery of meprins alpha(1), alpha(2) and beta in teleost fish provided the basis for uncovering their physiological functions by gene silencing in vivo. METHODOLOGY/PRINCIPAL FINDINGS: A Morpholino knockdown in zebrafish embryos targeting meprin alpha(1) and beta mRNA caused defects in general tissue differentiation. But meprin alpha(2) morphants were affected more…

Vascular Endothelial Growth Factor AMorpholinoAngiogenesisMorpholinesCellular differentiationlcsh:MedicineCell Biology/Cell SignalingBiochemistry/Protein ChemistryAnimalsGene silencingCardiovascular Disorders/Vascular Biologylcsh:ScienceZebrafishZebrafishMultidisciplinarybiologyCell growthPhysiology/Cardiovascular Physiology and Circulationlcsh:RMetalloendopeptidasesMorphantCardiovascular Disorders/Cardiovascular Imagingbiology.organism_classificationMolecular biologyCell biologyVascular endothelial growth factor AGene Knockdown TechniquesAngiogenesis Inducing Agentslcsh:QResearch ArticlePLoS ONE
researchProduct

Comparison of growth & function of endothelial progenitor cells cultured on deproteinized bovine bone modified with covalently bound fibronectin …

2016

Objectives The objective of this study was to assess and compare the growth and function of Endothelial Progenitor Cells (EPCs) cultured on covalently bonded Vascular Endothelial Growth Factor (VEGF) and covalently bonded Fibronectin (FN) coating on deproteinized bovine bone (DBB) (test samples), compared to non-modified DBB blocks (control sample). Materials and methods The test samples were prepared by plasma polymerization of allylamine onto DBB blocks. Group1 of test samples were prepared with VEGF coating (VEGF-DBB) where as the Group2 test samples were coated with FN (FN-DBB). Non-modified DBB blocks served as a Control. EPCs were isolated and cultivated from buffy coats of peripheral…

Vascular Endothelial Growth Factor ANitric Oxide Synthase Type IIIAngiogenesis0206 medical engineeringNitric Oxide Synthase Type IICell CountEnzyme-Linked Immunosorbent Assay02 engineering and technologyReal-Time Polymerase Chain ReactionCell morphologyAllylamine03 medical and health scienceschemistry.chemical_compound0302 clinical medicineEnosAnimalsHumansMTT assayProgenitor cellCells CulturedCell ProliferationEndothelial Progenitor CellsMicroscopy Confocalbiology030206 dentistrybiology.organism_classification020601 biomedical engineeringMolecular biologyFibronectinsVascular endothelial growth factorFibronectinchemistryBone SubstitutesImmunologybiology.proteinCattleOral SurgeryClinical Oral Implants Research
researchProduct

Vascular Endothelial Growth Factor-Releasing Microspheres Based on Poly(ε-Caprolactone-PEG-ε-Caprolactone)-b-Poly(L-Lactide) Multiblock Copolymers In…

2020

Pancreatic islet transplantation is a promising advanced therapy that has been used to treat patients suffering from diabetes type 1. Traditionally, pancreatic islets are infused via the portal vein, which is subsequently intended to engraft in the liver. Severe immunosuppressive treatments are necessary, however, to prevent rejection of the transplanted islets. Novel approaches therefore have focused on encapsulation of the islets in biomaterial implants which can protect the islets and offer an organ-like environment. Vascularization of the device’s surface is a prerequisite for the survival and proper func- tioning of transplanted pancreatic islets. We are pursuing a prevascularization s…

Vascular Endothelial Growth Factor APDMS implantsTime FactorsDrug CompoundingPolyestersPharmaceutical Science02 engineering and technology030226 pharmacology & pharmacyPolyethylene Glycols03 medical and health scienceschemistry.chemical_compound0302 clinical medicinePEG ratioHyaluronic acidHuman Umbilical Vein Endothelial CellsmedicineHumansDimethylpolysiloxanesHyaluronic Aciddiabetes type 1Cells CulturedCell Proliferationmultiblock copolymersDrug ImplantsDrug CarriersPancreatic isletsartificial pancreasBiomaterial021001 nanoscience & nanotechnologyControlled releaseVEGFMicrospheres3. Good healthVascular endothelial growth factorDrug Liberationmedicine.anatomical_structurechemistryPrinting Three-DimensionalAngiogenesis Inducing AgentsPancreatic islet transplantationcontrolled release PDMS implants VEGF multiblock copolymers diabetes type 1 artificial pancreas0210 nano-technologycontrolled releaseCaprolactoneBiomedical engineering
researchProduct

Ovine Carotid Artery-Derived Cells as an Optimized Supportive Cell Layer in 2-D Capillary Network Assays

2014

PLoS one 9(3), e91664 (2014). doi:10.1371/journal.pone.0091664

Vascular Endothelial Growth Factor APathologyCellBecaplerminlcsh:MedicineCardiovascularUmbilical veinUmbilical CordDrug DiscoveryMolecular Cell BiologyBiological Systems EngineeringMyocyteCardiovascular Imaginglcsh:ScienceMultidisciplinaryProto-Oncogene Proteins c-sisAnimal ModelsFlow CytometryEndothelial stem cellBevacizumabmedicine.anatomical_structureCarotid ArteriesMonoclonalMedicineImmunohistochemical AnalysisResearch ArticleBiotechnologymedicine.medical_specialtyCell typeDrugs and DevicesDrug Research and DevelopmentMyocytes Smooth MuscleImmunologyBiomedical EngineeringBioengineeringBiologyAntibodies Monoclonal HumanizedCell LineModel OrganismsVascular Biologymedicine.arterymedicineAnimalsHumansBiologySheeplcsh:REndothelial CellsFeeder CellsUmbilical arteryMolecular biologyVascular Endothelial Growth Factor Receptor-2Coculture TechniquesCapillariesCell cultureImmunologic Techniqueslcsh:QCytometry
researchProduct

Molecular imaging of VEGF in gastrointestinal cancer in vivo using confocal laser endomicroscopy

2010

Vascular endothelial growth factor (VEGF) is a therapeutic target in gastrointestinal cancer (GiC). However, its in vivo visualisation could not be achieved to date with endoscopic techniques. Confocal laser endomicroscopy (CLE) is a novel imaging technique for gastrointestinal endoscopy providing in vivo microscopy at subcellular resolution. The aim of the study was to evaluate CLE for in vivo molecular imaging of VEGF in GiC.Molecular imaging of tumours in APCmin mice, in xenograft models and in surgical specimens of patients with colorectal cancer (CRC) was achieved after application of labelled antibodies. The tumour sites were scanned with the probe for the strongest specific fluoresce…

Vascular Endothelial Growth Factor APathologymedicine.medical_specialtyGenes APCTransplantation HeterologousAdenocarcinomaEndoscopy Gastrointestinallaw.inventionMicechemistry.chemical_compoundConfocal microscopylawIn vivoTumor Cells CulturedmedicineAnimalsHumansGastrointestinal cancerGastrointestinal NeoplasmsMice KnockoutMicroscopy Confocalbusiness.industryfungiGastroenterologyCancerColonoscopymedicine.diseaseVascular Endothelial Growth Factor Receptor-2TransplantationVascular endothelial growth factorDisease Models AnimalchemistryImmunohistochemistryMolecular imagingColorectal NeoplasmsbusinessNeoplasm TransplantationGut
researchProduct

Anticancer therapy-induced vascular toxicity: VEGF inhibition and beyond

2017

Cardiotoxicity induced by chemotherapeutic agents and radiotherapy is a growing problem. In recent years, an increasing number of new drugs with targeted action have been designed. These molecules, such as monoclonal antibodies and tyrosine kinase inhibitors, can cause different type of toxicities compared to traditional chemotherapy. However, they can also cause cardiac complications such as heart failure, arterial hypertension, QT interval prolongation and arrhythmias. Currently, a field of intense research is the vascular toxicity induced by new biologic drugs, particularly those which inhibit vascular endothelial growth factor (VEGF) and its receptor (VEGF-R) and other tyrosine kinases.…

Vascular Endothelial Growth Factor APathologymedicine.medical_specialtyHeart Diseasesmedicine.medical_treatmentVascular toxicity VEGF cardiotoxicity new target therapy chemotherapy radiotherapy cardio-oncologyAntineoplastic Agents030204 cardiovascular system & hematologyQT intervalCardiooncology03 medical and health scienceschemistry.chemical_compoundCardio-oncology; Cardiotoxicity; Chemotherapy; New target therapy; Radiotherapy; Vascular toxicity; VEGF; Medicine (all); Cardiology and Cardiovascular Medicine0302 clinical medicineVascularReceptorsmedicineAnimalsHumansChemotherapyEndotheliumNew target therapyChemotherapyCardiotoxicityRadiotherapybusiness.industryVascular Endothelial Growth FactorMedicine (all)Cardiooncology; Vascular toxicity; New target therapyCardio-oncology; Cardiotoxicity; Chemotherapy; New target therapy; Radiotherapy; Vascular toxicity; VEGF; Animals; Antineoplastic Agents; Cardiotoxicity; Endothelium Vascular; Heart Diseases; Humans; Reactive Oxygen Species; Receptors Vascular Endothelial Growth Factor; Vascular Endothelial Growth Factor Amedicine.diseaseVEGFCardiotoxicityVascular endothelial growth factorRadiation therapyCardio-oncologyVascular endothelial growth factor AReceptors Vascular Endothelial Growth Factorchemistry030220 oncology & carcinogenesisHeart failureCancer researchEndothelium VascularVascular toxicityReactive Oxygen SpeciesCardiology and Cardiovascular MedicinebusinessTyrosine kinaseInternational Journal of Cardiology
researchProduct

Hypoxia-stimulated expression of angiogenic growth factors in cervical cancer cells and cervical cancer-derived fibroblasts

2001

It is generally accepted that local growth of solid tumors and their ability to establish distant metastases are dependent on the formation of new blood vessels arising from preexisting ones (angiogenesis). The angiogenic response of the host is mediated by angiogenic molecules that are released from cancer and normal stroma cells, especially fibroblasts. The goal of the present study was to quantitatively compare the expression of the two most important angiogenic growth factors (VEGF, angiogenin) of cervical cancer cells (HeLa and Me-180) with that of cervical cancer-derived fibroblasts (from one tumor/patient) under defined normoxic and hypoxic conditions in vitro. The growth kinetics of…

Vascular Endothelial Growth Factor APathologymedicine.medical_specialtyStromal cellAngiogeninAngiogenesismedicine.medical_treatmentCellUterine Cervical NeoplasmsEnzyme-Linked Immunosorbent AssayEndothelial Growth FactorsHeLamedicineHumansHypoxiaLymphokinesNeovascularization PathologicbiologyVascular Endothelial Growth FactorsGrowth factorObstetrics and GynecologyRibonuclease PancreaticFibroblastsbiology.organism_classificationIn vitroGene Expression Regulation NeoplasticKineticsmedicine.anatomical_structureOncologyCell cultureCancer researchFemaleCell DivisionHeLa CellsInternational Journal of Gynecological Cancer
researchProduct

High levels of HIF-2α highlight an immature neural crest-like neuroblastoma cell cohort located in a perivascular niche

2007

High HIF-2alpha protein levels in the sympathetic nervous system-derived childhood tumour neuroblastoma as well as immature phenotype correlate to unfavourable outcome. Here we show that a small subset of perivascularly located, strongly HIF-2alpha-positive tumour cells (MYCN amplified) lacks expression of differentiation markers, but expresses neural crest and early sympathetic progenitor marker genes such as Notch-1, HES-1, c-Kit, dHAND, and vimentin. HIF-2alpha- and CD68-positive tumour-associated macrophages were frequently found close to the immature and HIF-2alpha-positive neuroblastoma cells and as VEGF levels are high in the perivascular niche, we hypothesize that neuroblastoma neur…

Vascular Endothelial Growth Factor APathologymedicine.medical_specialtySympathetic Nervous SystemAngiogenesisVimentinPathology and Forensic MedicineNeuroblastomaNeuroblastomaBasic Helix-Loop-Helix Transcription FactorsTumor Cells CulturedmedicineHumansMacrophageProgenitorOncogene ProteinsN-Myc Proto-Oncogene ProteinNeovascularization PathologicbiologyMacrophagesNuclear ProteinsNeural crestmedicine.diseasePhenotypeCell HypoxiaNeoplasm ProteinsNeural CrestNeoplastic Stem Cellsbiology.proteinCancer researchStem cellThe Journal of Pathology
researchProduct

Scaffold vascularization in vivo driven by primary human osteoblasts in concert with host inflammatory cells.

2011

Successful cell-based tissue engineering requires a rapid and thorough vascularization in order to ensure long-term implant survival and tissue integration. The vascularization of a scaffold is a complex process, and is modulated by the presence of transplanted cells, exogenous and endogenous signaling proteins, and the host tissue reaction, among other influencing factors. This paper presents evidence for the significance of pre-seeded osteoblasts for the in vivo vascularization of a biodegradable scaffold. Human osteoblasts, cultured on silk fibroin micronets in vitro, migrated throughout the interconnected pores of the scaffold and produced extensive bone matrix. When these constructs we…

Vascular Endothelial Growth Factor AScaffoldMaterials scienceTime FactorsAngiogenesisCellBiophysicsFibroinNeovascularization PhysiologicBioengineeringMice SCIDBiomaterialsProsthesis ImplantationMiceTissue engineeringIn vivomedicineAnimalsHumansCells CulturedInflammationOsteoblastsTissue ScaffoldsIn vitroCell biologymedicine.anatomical_structureMechanics of MaterialsGiant cellCeramics and CompositesBlood VesselsFibroinsBiomedical engineeringBiomaterials
researchProduct

The impact of the receptor binding profiles of the vascular endothelial growth factors on their angiogenic features

2013

Abstract Background Vascular endothelial growth factors (VEGFs) are potential therapeutic agents for treatment of ischemic diseases. Their angiogenic effects are mainly mediated through VEGF receptor 2 (VEGFR2). Methods Receptor binding, signaling, and biological efficacy of several VEGFR2 ligands were compared to determine their characteristics regarding angiogenic activity and vascular permeability. Results Tested VEGFR2 ligands induced receptor tyrosine phosphorylation with different efficacy depending on their binding affinities. However, the tyrosine phosphorylation pattern and the activation of the major downstream signaling pathways were comparable. The maximal angiogenic effect stim…

Vascular Endothelial Growth Factor ASwineAngiogenesisBlotting WesternBiophysicsNeovascularization PhysiologicVascular permeabilityBiologyBiochemistryCapillary Permeabilitychemistry.chemical_compoundCell MovementHuman Umbilical Vein Endothelial CellsNeuropilinAnimalsHumansImmunoprecipitationPhosphorylationReceptorMolecular BiologyAortaCells CulturedCell Proliferationta1182Tyrosine phosphorylationrespiratory systemLigand (biochemistry)Vascular Endothelial Growth Factor Receptor-2Cell biologyVascular endothelial growth factorEndothelial stem cellchemistryBiochemistrycardiovascular systemEndothelium VascularPlasmidsSignal Transductioncirculatory and respiratory physiologyBiochimica et Biophysica Acta (BBA) - General Subjects
researchProduct